Dorzagliatin (HMS5552), a novel dual-acting glucokinase activator, improves glycaemic control and pancreatic -cell function in patients with type 2 diabetes: A 28-day treatment study using biomarker-guided patient selection
Whether youre recovering from illness, managing fatigue, or simply want a wellness boost, IV therapy can support hydration, immune health, and energy levels
Pulidindi K, Ahuja K
Revised 03/2025 PRINCIPAL DISPLAY PANEL - Kit Carton - 450 IU NDC 44087-9030-1 GONAL-f (follitropin alfa) for injection 450 IU/vial For subcutaneous injection Rx only 1 Multiple-dose vial 1 pre-filled syringe of Bacteriostatic Water for Injection, USP (0.9% benzyl alcohol) 6 administration syringes with fixed needle (27-gauge) EMD SERONO PRINCIPAL DISPLAY PANEL - Kit Carton - 1050 IU NDC 44087-9070-1 GONAL-f (follitropin alfa) for injection 1050 IU/vial For subcutaneous injection Rx only 1 Multiple-dose vial 1 pre-filled syringe of Bacteriostatic Water for Injection, USP (0.9% benzyl alcohol) 10 administration syringes with fixed needle (27-gauge) EMD SERONO EMD Serono, Inc.
trans-(-)--Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington disease
Peptides like thymosin alpha-1 that support regulatory T-cell function can benefit both conditions
